Co-Authors
This is a "connection" page, showing publications co-authored by Francesco Curcio and Carlo Tascini.
Connection Strength
1.856
-
Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19. Eur J Clin Microbiol Infect Dis. 2021 Dec; 40(12):2597-2604.
Score: 0.240
-
The Fall in Antibody Response to SARS-CoV-2: a Longitudinal Study of Asymptomatic to Critically Ill Patients Up to 10 Months after Recovery. J Clin Microbiol. 2021 10 19; 59(11):e0113821.
Score: 0.240
-
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021 Oct; 27(10):1507-1513.
Score: 0.237
-
MR-proADM as prognostic factor of outcome in COVID-19 patients. Sci Rep. 2021 03 04; 11(1):5121.
Score: 0.233
-
Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia. Cytokine. 2021 04; 140:155438.
Score: 0.231
-
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care. J Clin Virol. 2020 08; 129:104444.
Score: 0.221
-
A cluster of COVID-19 cases in a small Italian town: a successful example of contact tracing and swab collection. Clin Microbiol Infect. 2020 08; 26(8):1112-1114.
Score: 0.220
-
CORonavirus-19 mild to moderate pneumonia Management with blood Ozonization in patients with Respiratory failure (CORMOR) multicentric prospective randomized clinical trial. Int Immunopharmacol. 2021 Sep; 98:107874.
Score: 0.059
-
Mid-regional pro-adrenomedullin as a supplementary tool to clinical parameters in cases of suspicion of infection in the emergency department. Expert Rev Mol Diagn. 2021 04; 21(4):397-404.
Score: 0.059
-
Response to a massive SARS-CoV-2 infection in a nursing home transformed into a caring center. Aging Clin Exp Res. 2021 Feb; 33(2):443-450.
Score: 0.058
-
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome. Neurol Sci. 2020 Dec; 41(12):3391-3394.
Score: 0.057